We’re raising our price target on Eli Lilly as the obesity-drug boom rolls on

The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there’s more growth to be had.The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there’s more growth to be had.